These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 36533576)

  • 41. Down-regulated FSTL5 promotes cell proliferation and survival by affecting Wnt/β-catenin signaling in hepatocellular carcinoma.
    Zhang D; Ma X; Sun W; Cui P; Lu Z
    Int J Clin Exp Pathol; 2015; 8(3):3386-94. PubMed ID: 26045876
    [TBL] [Abstract][Full Text] [Related]  

  • 42. FSTL1 interacts with VIM and promotes colorectal cancer metastasis via activating the focal adhesion signalling pathway.
    Gu C; Wang X; Long T; Wang X; Zhong Y; Ma Y; Hu Z; Li Z
    Cell Death Dis; 2018 May; 9(6):654. PubMed ID: 29844309
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cross-Talk Between TGF-β and NADPH Oxidases During Liver Fibrosis and Hepatocarcinogenesis.
    Crosas-Molist E; Bertran E; Fabregat I
    Curr Pharm Des; 2015; 21(41):5964-76. PubMed ID: 26510436
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Angiocrine FSTL1 (Follistatin-Like Protein 1) Insufficiency Leads to Atrial and Venous Wall Fibrosis via SMAD3 Activation.
    Jiang H; Zhang L; Liu X; Sun W; Kato K; Chen C; Li X; Li T; Sun Z; Han W; Zhang F; Xiao Q; Yang Z; Hu J; Qin Z; Adams RH; Gao X; He Y
    Arterioscler Thromb Vasc Biol; 2020 Apr; 40(4):958-972. PubMed ID: 32078339
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Follistatin-like protein 1 (FSTL1) promotes chondrocyte expression of matrix metalloproteinase and inflammatory factors via the NF-κB pathway.
    Hu PF; Ma CY; Sun FF; Chen WP; Wu LD
    J Cell Mol Med; 2019 Mar; 23(3):2230-2237. PubMed ID: 30644158
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Follistatin-like 1 suppresses osteoblast differentiation of bone marrow mesenchymal cells during inflammation.
    Jin QY; Zhu QH; Deng W; Hou CX; Sun NN; Han W; Tang YT; Wang CX; Ye JH
    Arch Oral Biol; 2022 Mar; 135():105345. PubMed ID: 35026647
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cardiac myocyte follistatin-like 1 functions to attenuate hypertrophy following pressure overload.
    Shimano M; Ouchi N; Nakamura K; van Wijk B; Ohashi K; Asaumi Y; Higuchi A; Pimentel DR; Sam F; Murohara T; van den Hoff MJ; Walsh K
    Proc Natl Acad Sci U S A; 2011 Oct; 108(43):E899-906. PubMed ID: 21987816
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Follistatin like protein-1 modulates macrophage polarization and aggravates dextran sodium sulfate-induced colitis.
    Li G; Ren H; Wu X; Hu Q; Hong Z; Wang G; Gu G; Ren J; Li J
    Int Immunopharmacol; 2020 Jun; 83():106456. PubMed ID: 32247265
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mitotic cell death caused by follistatin-like 1 inhibition is associated with up-regulated Bim by inactivated Erk1/2 in human lung cancer cells.
    Bae K; Park KE; Han J; Kim J; Kim K; Yoon KA
    Oncotarget; 2016 Apr; 7(14):18076-84. PubMed ID: 26716515
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Follistatin-like 1 in chronic systolic heart failure: a marker of left ventricular remodeling.
    El-Armouche A; Ouchi N; Tanaka K; Doros G; Wittköpper K; Schulze T; Eschenhagen T; Walsh K; Sam F
    Circ Heart Fail; 2011 Sep; 4(5):621-7. PubMed ID: 21622850
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Deletion of Fstl1 (Follistatin-Like 1) From the Endocardial/Endothelial Lineage Causes Mitral Valve Disease.
    Prakash S; Borreguero LJJ; Sylva M; Flores Ruiz L; Rezai F; Gunst QD; de la Pompa JL; Ruijter JM; van den Hoff MJB
    Arterioscler Thromb Vasc Biol; 2017 Sep; 37(9):e116-e130. PubMed ID: 28705792
    [TBL] [Abstract][Full Text] [Related]  

  • 52. FSTL1 Promotes Metastasis and Chemoresistance in Esophageal Squamous Cell Carcinoma through NFκB-BMP Signaling Cross-talk.
    Lau MC; Ng KY; Wong TL; Tong M; Lee TK; Ming XY; Law S; Lee NP; Cheung AL; Qin YR; Chan KW; Ning W; Guan XY; Ma S
    Cancer Res; 2017 Nov; 77(21):5886-5899. PubMed ID: 28883005
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Follistatin-Like Protein-1 Upregulates Dendritic Cell-Based Immunity in Patients with Nasopharyngeal Carcinoma.
    Wang H; Huang S; Wu S; Yin S; Tang A; Wen W
    J Interferon Cytokine Res; 2017 Nov; 37(11):494-502. PubMed ID: 29135371
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fstl1 Promotes Glioma Growth Through the BMP4/Smad1/5/8 Signaling Pathway.
    Jin X; Nie E; Zhou X; Zeng A; Yu T; Zhi T; Jiang K; Wang Y; Zhang J; You Y
    Cell Physiol Biochem; 2017; 44(4):1616-1628. PubMed ID: 29212066
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Follistatin-like protein 1 and its role in inflammation and inflammatory diseases.
    Chaly Y; Hostager B; Smith S; Hirsch R
    Immunol Res; 2014 Aug; 59(1-3):266-72. PubMed ID: 24838142
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Follistatin-like 1 deficiency impairs T cell development to promote lung metastasis of triple negative breast cancer.
    Ma J; Yang Y; Wang L; Jia X; Lu T; Zeng Y; Liu L; Gao Y
    Aging (Albany NY); 2021 Feb; 13(5):7211-7227. PubMed ID: 33639614
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Innate immune activation of astrocytes impairs neurodevelopment via upregulation of follistatin-like 1 and interferon-induced transmembrane protein 3.
    Yamada S; Itoh N; Nagai T; Nakai T; Ibi D; Nakajima A; Nabeshima T; Yamada K
    J Neuroinflammation; 2018 Oct; 15(1):295. PubMed ID: 30348171
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Molecular functions of FSTL1 in the osteoarthritis.
    Li W; Alahdal M; Deng Z; Liu J; Zhao Z; Cheng X; Chen X; Li J; Yin J; Li Y; Wang G; Wang D; Tang K; Zhang J
    Int Immunopharmacol; 2020 Jun; 83():106465. PubMed ID: 32259701
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reduced transforming growth factor-beta receptor II expression in hepatocellular carcinoma correlates with intrahepatic metastasis.
    Mamiya T; Yamazaki K; Masugi Y; Mori T; Effendi K; Du W; Hibi T; Tanabe M; Ueda M; Takayama T; Sakamoto M
    Lab Invest; 2010 Sep; 90(9):1339-45. PubMed ID: 20531292
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Transforming growth factor-beta 1, activin and follistatin in patients with hepatocellular carcinoma and patients with alcoholic cirrhosis.
    Yuen MF; Norris S; Evans LW; Langley PG; Hughes RD
    Scand J Gastroenterol; 2002 Feb; 37(2):233-8. PubMed ID: 11843063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.